Movira, Reymond J.

HRN: 23-14-55  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2023
CEFTRIAXONE 1G (VIAL)
06/13/2023
06/20/2023
IV
2g
Q24hrs
Acute Appendicitis With Phlegmon
Waiting Final Action 
06/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/14/2023
06/21/2023
IV
500mg
Q8hrs
Acute Appendicitis
Waiting Final Action 
06/04/2024
CEFTRIAXONE 1G (VIAL)
06/04/2024
06/11/2024
IV
2g
Q24
Partial Bowel Obstruction
Waiting Final Action 
06/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/04/2024
06/11/2024
IV
500mg
Q8
Partial Bowel Obstruction
Waiting Final Action 
06/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/04/2024
06/11/2024
IV
500mg
Q8
Partial Bowel Obstruction
Waiting Final Action 
06/19/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/19/2024
06/26/2024
IV
4.5 G
Every 8 Hours
Gut Obstruction
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: